FDA clears PETNet for commercial 18F FDG sales

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Siemens subsidiary PETNet has been granted FDA approval for its Abbreviated New Drug Application (ANDA) for fludeoxyglucose F 18 (18F FDG) injection.

The approval readies PetNet to manufacture and distribute 18F FDG for PET imaging from one of the company’s 54 global production and distribution sites. PetNet is the first company to receive FDA approval for commercial sale of the biomarker, the Knoxville, Tenn.-based company said.